Ylva Gravenfors
Medicinal Chemistry Hit2Lead
We are medicinal chemists and we design and synthesize new compounds to accelerate academic drug discovery projects.
We would like to invent new medicines to treat different diseases. Drug discovery is challenging and complex and to be successful you need to understand the underlying cause of the disease, set up system to evaluate the potential and limitations with the compounds made and also to evaluate the approach selected to treat the disease. We do this in collaboration with the other facilities at SciLifeLab Drug Discovery and Development platform and Swedish academic groups with the goal to develop a new drug.
Group Members
- Christoffer Bengtsson
- Rémi Caraballo
- Fredrik Klingegård
- Lars Sandberg
- Birger Sjöberg